Hopf bifurcation analysis in a delayed model of tumor therapy with oncolytic viruses
From MaRDI portal
Publication:3390748
Recommendations
- Hopf-bifurcation analysis of a delayed model for the treatment of cancer using virotherapy
- Hopf bifurcation analysis of a tumor virotherapy model with two time delays
- Hopf bifurcation analysis in a delayed system for cancer virotherapy
- Hopf bifurcation analysis and optimal control of treatment in a delayed oncolytic virus dynamics
- Hopf bifurcation analysis in a delayed oncolytic virus dynamics with continuous control
- A delayed fractional-order tumor virotherapy model: stability and Hopf bifurcation
- Bifurcation analysis of the cancer virotherapy system with time delay and diffusion
- Hopf bifurcation on a cancer therapy model by oncolytic virus involving the malignancy effect and therapeutic efficacy
- Backward Hopf bifurcation in a mathematical model for oncolytic virotherapy with the infection delay and innate immune effects
- Hopf bifurcation in oncolytic therapeutic modeling: viruses as anti-tumor means with viral lytic cycle
Cited in
(10)- Oscillation thresholds via the novel MBR method with application to oncolytic virotherapy
- Hopf bifurcation in a model for adult T-cell leukemia
- Bifurcation analysis in a model of cytotoxic T-lymphocyte response to viral infections
- Hopf bifurcation analysis in a delayed oncolytic virus dynamics with continuous control
- Hopf bifurcation in oncolytic therapeutic modeling: viruses as anti-tumor means with viral lytic cycle
- Hopf bifurcation analysis of a phage therapy model
- HOPF BIFURCATION ANALYSIS FOR A MATHEMATICAL MODEL OF P53-MDM2 INTERACTION
- Bifurcation analysis of the cancer virotherapy system with time delay and diffusion
- Hopf bifurcation analysis in a delayed system for cancer virotherapy
- Hopf bifurcation on a cancer therapy model by oncolytic virus involving the malignancy effect and therapeutic efficacy
This page was built for publication: Hopf bifurcation analysis in a delayed model of tumor therapy with oncolytic viruses
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3390748)